Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

GSH-dependent redox regulation and antioxidant enzymes in the formation of resistance to doxorubicin in K562 human erythroleukemia cells.

Kalinina E, Novichkova M, Scherbak NP, Solomka V, Saprin AN.

Adv Exp Med Biol. 2001;500:241-4. No abstract available.

PMID:
11764946
2.

[Role of the antioxidant system and redox-dependent regulation of transcription factors bcl-2 and p53 in forming resistance of human K562 erythroleukemia cells to doxorubicin].

Kalinina EV, Saprin AN, Solomka VS, Shcherbak NP, Chermnykh NS, Piruzian LA.

Vopr Onkol. 2001;47(5):595-600. Russian.

PMID:
11785103
3.

Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype.

Schisselbauer JC, Crescimanno M, D'Alessandro N, Clapper M, Toulmond S, Tapiero H, Tew KD.

Cancer Commun. 1989;1(2):133-9.

PMID:
2639724
4.

Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.

Crescimanno M, D'Alessandro N, Armata MG, Toulmond S, Tapiero H.

Anticancer Res. 1991 Mar-Apr;11(2):901-3.

PMID:
2064348
5.

Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.

Kim HS, Lee TB, Choi CH.

Biochem Biophys Res Commun. 2001 Feb 16;281(1):109-14.

PMID:
11178967
6.

[Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin].

Liu H, Fu RY, Liao QK, Li FY, Zhu YP, Gao J, Mao YQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Jan;40(1):133-7. Chinese.

PMID:
19292063
7.

Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin-transferrin conjugate.

Szwed M, Kania KD, Jozwiak Z.

Biochimie. 2014 Dec;107 Pt B:358-66. doi: 10.1016/j.biochi.2014.10.005. Epub 2014 Oct 13.

PMID:
25312849
9.

Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes.

Babson JR, Abell NS, Reed DJ.

Biochem Pharmacol. 1981 Aug 15;30(16):2299-304. No abstract available.

PMID:
7295342
10.

Inhibition of c-Jun expression induces antioxidant enzymes under serum deprivation.

Kim YH, Takahashi M, Noguchi N, Suzuki E, Suzuki K, Taniguchi N, Niki E.

Arch Biochem Biophys. 2000 Feb 15;374(2):339-46.

PMID:
10666316
11.

Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy.

Gustafson DL, Swanson JD, Pritsos CA.

Free Radic Res Commun. 1993;19(2):111-20.

PMID:
8225037
12.

Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells.

Wang JH, Du JP, Li SJ, Zhai LP, Yang XY, Wang ZH, Wu ZT, Han Y.

J Dig Dis. 2012 Mar;13(3):143-52. doi: 10.1111/j.1751-2980.2011.00563.x.

PMID:
22356309
13.

[Activity of glutathione-dependent enzymes, catalase and superoxide dismutase in the liver and myocardium of rats with vitamin A deficiency].

Pentiuk AA, Iakovleva OA, Konovalova GG, Lankin VZ.

Biokhimiia. 1987 Jun;52(6):1009-12. Russian.

PMID:
2889476
14.
15.
16.

A stable O2-resistant cell line: role of lipid peroxidation byproducts in O2-mediated injury.

Sullivan SJ, Oberley TD, Roberts RJ, Spitz DR.

Am J Physiol. 1992 Jun;262(6 Pt 1):L748-56.

PMID:
1616058
17.

Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate.

Tashiro K, Asakura T, Fujiwara C, Ohkawa K, Ishibashi Y.

Anticancer Drugs. 2001 Sep;12(8):707-12.

PMID:
11604559
18.

Effect of endotoxemia on skin antioxidant enzymes under experimental conditions.

Ivanova AV, Mikhal'chik EV, Miroshnikova EA, Lukasheva EV, Korkina LG.

Bull Exp Biol Med. 2006 Oct;142(4):413-5. English, Russian.

PMID:
17415424
19.

Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.

Cole SP, Downes HF, Mirski SE, Clements DJ.

Mol Pharmacol. 1990 Feb;37(2):192-7.

PMID:
1968221
20.

[Activity of antioxidant enzymes in patients with liver cirrhosis].

Czeczot H, Scibior D, Skrzycki M, Podsiad M.

Wiad Lek. 2006;59(11-12):762-6. Polish.

PMID:
17427488

Supplemental Content

Support Center